Visium Asset Management’s Eli Lilly LLY Stock Holding History

Visium Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-4,800	Closed	-$401K	–	1071
2015 Q2	$401K	Sell	4,800 -39,974	-89%	-$3.05M	0.01%	719
2015 Q1	$3.25M	Buy	44,774 +27,368	+157%	+$1.95M	0.05%	338
2014 Q4	$1.2M	Buy	17,406 +10,106	+138%	+$682K	0.02%	502
2014 Q3	$473K	Buy	7,300 +1,900	+35%	+$120K	0.01%	787
2014 Q2	$336K	Sell	5,400 -13,810	-72%	-$824K	0.01%	856
2014 Q1	$1.13M	Sell	19,210 -96,047	-83%	-$5.36M	0.02%	461
2013 Q4	$5.88M	Buy	115,257 +4,345	+4%	+$218K	0.12%	175
2013 Q3	$5.58M	Sell	110,912 -109,693	-50%	-$5.74M	0.13%	134
2013 Q2	$10.8M	Buy	+220,605	New	+$12M	0.25%	74

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Visium Asset Management's LLY Position: Q3 2015 in Review

Visium Asset Management sold out of Eli Lilly (LLY) in Q3 2015, closing a stake of 4,800 shares — an estimated $401K sold.

Visium Asset Management first reported a position in LLY in Q2 2013 and held it in 9 quarters. The position peaked at $10.8M in Q2 2013. 1,147 funds tracked by Wall St. Rank hold LLY as of Q3 2015.

Visium Asset Management reported no remaining Eli Lilly position as of Q3 2015 after selling out during the quarter.
Visium Asset Management sold 4,800 Eli Lilly shares in Q3 2015, an estimated $401K.
Visium Asset Management first reported a position in Eli Lilly in Q2 2013 and held it in 9 quarters.
Visium Asset Management's Eli Lilly position peaked at $10.8M in Q2 2013.
1,147 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2015.

Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.